期刊文献+

延肾胶囊对部分肾切除大鼠肾脏CB表达的影响 被引量:12

The Effects and Mechanism of Yanshen Capsule on the Remnant Kidney
在线阅读 下载PDF
导出
摘要 目的:探讨延肾胶囊抑制5/6肾切除大鼠残肾纤维化、延缓慢性肾衰竭的作用机制。方法:取健康Wistar大鼠30只,随机分成假手术对照组、手术组和延肾胶囊治疗组。采用生物化学、形态计量、免疫组化技术检测各组大鼠术后60 d肾功能、肾组织形态学、肾组织蛋白酶B(CB)和Ⅳ型胶原表达。结果:延肾胶囊治疗组比手术组血清肌酐、尿素氮水平明显下降,肾小球硬化程度明显减轻;免疫组化显示,治疗组比手术组大鼠CB表达增多,Ⅳ型胶原表达减少。结论:延肾胶囊可能通过促进CB表达增加,降解Ⅳ型胶原等细胞外基质而抑制5/6肾切除大鼠残肾组织纤维化。 Objective:To explore the effects and mechanism of Yanshen Capsule on the remnant kidney. Methods: Thirty healthy Wistar rats were randomly divided into 3 groups: control group rats were sham - operated and gavaged with saline daily, operation group rats were 5/6 nephrectomized and garaged with saline daily, treatment group rats were 5/6 nephrectomized and garaged with Yanshen Capsule daily. The body weight(BW), blood urea nitrogen(BUN) and ereatinine (Scr) levels, renal morphological changes, the expression of collagen Ⅳ (Col Ⅳ ) and cathepsin B (CB) were observed using biochemistry, morphometry and immunohistochemistry at 60 days after operation. Results: The BUN and Scr of Yanshen Capsule- treated group also slightly higher than that of control group, but were significantly lower than that of operation group(P 〈 0.01 ). In Yartshen Catxsule- treated group, lower ratio of sclerosis glomeruli, higher exprssion of CB and lower expression of Col Ⅳ were observed compared to that of operation group. Conelusion: Yanshen Capsule retards the development of renal fibrosis through increasing CB and suppressing Col Ⅳ.
出处 《中国中西医结合肾病杂志》 2006年第3期143-145,共3页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 肾纤维化 组织蛋白酶B 残肾 大鼠 Renal fibrosis CathepsinB Remnant kidney Rat
作者简介 通讯作者
  • 相关文献

参考文献8

  • 1Yuan FH,Guang LX,Liao LS.The experimental study for mechanism of retarding the lesion progress of remnant kidney by Yan-Shen Capsule.American Joural of Oriental Medicine Research,1998,1(3):151-152.
  • 2袁发焕,光丽霞,廖立生.延肾胶囊延缓残肾肾损伤机理的实验研究.见:夏洪生.国际中西医结合研究.香港:香港新闻出版社,1997.155-157.
  • 3Barisoni L,Kopp JB.Modulation of podocyte phenotype in collapsing glomerulopathies.Microsc Res Tech,2002,57(4):254-262.
  • 4Yang Y,Zhang SY,Sich M,et al.Glomerular extracellular matrix and growth factors in diffuse mesangial sclerosis.Pediatr Nephrol,2001,16(5):429-438.
  • 5Szpaderska AM,Silberman S,Ahmec Y,et al.Sp1 regulates cathepsin B transcription and invasiveness in murine B16 melanoma cells.Anticancer Res,2004,24(6):3887-3891.
  • 6Koslowski R,Knoch K,Kuhlisch E,et al.Cathepsins in bleomycin-induced lung injury in rat.Eur Respir J,2003,22(3):427-435.
  • 7Canbay A,Guicciardi ME,Higuchi H,et al.Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis.J Clin Invest,2003,112(2):152-159.
  • 8Suzuki H,Schaefer L,Ling H,et al.Prevention of cardiac hypertrophy in experimental chronic renal failure by long-term ACE inhibitor administration:potential role of lysosomal proteinases.Am J Nephrol,1995,15(2):129-136.

同被引文献122

引证文献12

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部